SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-162797
Filing Date
2021-05-17
Accepted
2021-05-17 07:53:19
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d118581d10q.htm   iXBRL 10-Q 601370
2 EX-31.1 d118581dex311.htm EX-31.1 11122
3 EX-31.2 d118581dex312.htm EX-31.2 11144
4 EX-32.1 d118581dex321.htm EX-32.1 4943
5 EX-32.2 d118581dex322.htm EX-32.2 4965
  Complete submission text file 0001193125-21-162797.txt   3174982

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA galt-20210331.xsd EX-101.SCH 31864
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20210331_cal.xml EX-101.CAL 22053
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20210331_def.xml EX-101.DEF 235005
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20210331_lab.xml EX-101.LAB 277636
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20210331_pre.xml EX-101.PRE 259929
11 EXTRACTED XBRL INSTANCE DOCUMENT d118581d10q_htm.xml XML 295508
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 21927622
SIC: 2834 Pharmaceutical Preparations